Search

MSK's 44th annual Academic Convocation and Commencement celebrated the Gerstner Sloan Kettering Graduate School of Biomedical Sciences class of 2023, honored students graduating from the Sloan Kettering Division of the Weill Cornell Medicine Graduate School of Medical Sciences, and recognized winners of several awards and fellowships.

… Friday, May 19, 2023 A record number of students graduated this year with doctoral degrees in cancer biology from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK) — the educational division of Memorial Sloan Kettering Cancer Center (MSK). There were 17 graduates receiving their

Various facilities provide the services and technology that support Memorial Sloan Kettering’s cancer genomics studies.

… Wednesday, November 14, 2012 Summary Various facilities provide the services and technology that support Memorial Sloan Kettering’s cancer genomics studies. A range of facilities provide expert services and technology to support cancer genomics studies at Memorial Sloan Kettering. The Integrated Genomics

A new study is challenging the perception that mesothelioma affects only older men. Learn why MSK experts say the medical community should be aware of this rare cancer's early symptoms.

… Tuesday, March 31, 2026 Mesothelioma , a rare cancer that usually starts in the lining around the lungs, has long been thought of as a condition that affects older men — especially those who may have been exposed to asbestos while working in manufacturing or construction. About 3,300 people are diagnosed

This three-part series summarizes MSK’s recent advances in clinical research and novel treatment approaches for rare head and neck cancers.

… Friday, March 22, 2024 Part 1: Rare Salivary Cancers Memorial Sloan Kettering Cancer Center (MSK) has a comprehensive and integrated head and neck cancer program with dedicated resources and specialists who treat patients with rare salivary, thyroid, non-melanoma skin, and oral cavity cancers. Clinical

Findings Could Inform the Development of a Blood Test for Early Cancer Detection

… Saturday, June 3, 2017 Findings from an early study evaluating a sophisticated new genomic-sequencing approach that analyzes cell-free DNA (cfDNA) in the blood of people with advanced cancer will help inform development of a future assay that could potentially detect cancer in its earliest stages, according

Most children face pressures growing up — including from their parents and peers. Vik Gill wrestled with circumstances “that may sound more familiar to any child of first-generation immigrants.

… Friday, May 6, 2022 Most children face pressures growing up — including from their parents and peers. Vik Gill wrestled with circumstances “that may sound more familiar to any child of first-generation immigrants,” he says “I was raised in a pretty culturally Indian household,” says Vik, an analyst for

A multicenter team led by Memorial Sloan Kettering neurologist and researcher Ingo K. Mellinghoff has uncovered the relationship between two proteins that play a critical role in glioblastoma, the most common form of brain cancer.

… Thursday, July 1, 2010 Summary A multicenter team led by Memorial Sloan Kettering neurologist and researcher Ingo K. Mellinghoff has uncovered the relationship between two proteins that play a critical role in glioblastoma, the most common form of brain cancer. A multicenter team led by Memorial Sloan

Hartford Healthcare system in Connecticut has been selected as the first MSK Cancer Alliance member, established to enhance delivery of care, improve patient outcomes, and advance research.

… Tuesday, September 17, 2013 Summary Hartford Healthcare system in Connecticut has been selected as the first MSK Cancer Alliance member, established to enhance delivery of care, improve patient outcomes, and advance research. Memorial Sloan Kettering today launched a transformative initiative to improve

Scott Stuart, Chair of the Boards of Trustees and Governing Trustees at Memorial Sloan Kettering Cancer Center (MSK), has been recognized as a Notable Nonprofit Board Leader in the 2023 Crain’s New York Business special editorial feature.

… Tuesday, October 10, 2023 Scott Stuart, Chair of the Boards of Trustees and Governing Trustees at Memorial Sloan Kettering Cancer Center (MSK), has been recognized as a Notable Nonprofit Board Leader in the 2023 Crain’s New York Business special editorial feature. This list honors exceptional nonprofit

Dr. Mara Sherman's lab at the Sloan Kettering Institute is “all pancreas, all the time.” Learn how her research program is illuminating interactions between cancer cells and the dense weave of fibrous cells that surrounds and protects pancreatic tumors.

… Monday, June 24, 2024 While the overall five-year survival rate for pancreatic cancer is slowly improving, it remains discouragingly low — just 13%, according to the American Cancer Society . And the odds are even worse if the cancer is discovered after it has spread to other organs. Dr. Mara Sherman